BackAlamar Biosciences Overview

Alamar Biosciences Total Liabilities

Track Alamar Biosciences's total liabilities ($360M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$364.52M

Peer average / median

Loading

Alamar Biosciences Total Liabilities History

Loading

Alamar Biosciences vs. peers: Total Liabilities Comparison

Loading

Alamar Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alamar Biosciences (ALMR) FAQ

As of the most recent data (March 2026), ALMR shows a total liabilities of $360M. Scroll down for historical charts and peer comparison views.

Tracking ALMR's total liabilities over time shows whether Alamar Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $360M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Alamar Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $360M) with ownership activity and broader fundamentals.

Alamar Biosciences's total liabilities is $360M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.